Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano-C is a leading developer of nanostructured carbon materials, including fullerenes and carbon nanotubes, with significant applications in the life sciences and healthcare sectors. The company leverages its proprietary carbon chemistry to design and manufacture high-purity materials used in targeted drug delivery, diagnostic imaging, and novel therapeutics. Their life science division focuses on the unique antioxidant properties of fullerenes to treat diseases driven by oxidative stress, such as neurodegeneration and inflammation. By providing specialized chemical functionalization, Nano-C enables the integration of carbon nanostructures into biological systems for enhanced efficacy and safety. The company operates through a combination of materials supply, collaborative R&D, and internal program development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano-C.